BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Legal Briefs
Texas Psychiatrists Accused of Accepting Bribes from AstraZeneca PLC (AZN) to Manipulate State Formulary 4/24/2015
In Largest Settlement Of Its Kind, Teva (TEVA) Will Pay $512 Million to Resolve Pay-to-Delay Case 4/21/2015
Pfizer (PFE) Victorious in First Trial Over Zoloft Birth Defect Claims 4/20/2015
Patient Dies Using Drug With Active Ingredients Like Biogen (BIIB)'s Tecfidera 4/13/2015
Amgen (AMGN) Devastated as Novartis AG (NVS) Wins Approval to Sell First-of-a-Kind Copycat Drug 3/24/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry 3/20/2015
Ex-Workers Accuse Novartis AG (NVS)'s Alcon (ACL) of Being Sexist, Maintaining a Boy's Club Atmosphere 3/19/2015
Johnson & Johnson (JNJ) Unit Pleads Guilty for Knowingly Selling Tainted Children's Tylenol 3/12/2015
GlaxoSmithKline (GSK) to Fire 110 Staffers in China for Violating Policy 3/6/2015
Neigbors Sue Roche (RHHBY) for Being Negligent With Handling of Hazardous Chemicals That Contaminated Land 3/6/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Hedge Fund Manager Picks Acorda Therapeutics (ACOR) as His First Victim Against the Pharmaceutical Industry and Its "BS" Patents 2/12/2015
AstraZeneca PLC (AZN) to Shell Out $7.9 Million in Kickback Scandal 2/12/2015
Ex-Merck & Co. (MRK) Analyst Facing Insider Trading Charges to Plead Guilty 2/10/2015
Merck & Co. (MRK) Scientist Threatened with Jail Time for Trying to Expose Huge Vaccine Data Manipulation and Fraud 2/9/2015
After Gilead (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
J.P. Morgan: AstraZeneca PLC (AZN) CEO Says He's Not Worried About Pricing Pressure 1/15/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
More Trouble for Retrophin (RTRX) Founder 1/9/2015
Pfizer (PFE)'s Antipsychotic Geodon Could Cause Fatal Skin Reaction: FDA 12/15/2014
Gilead Sciences, Inc. (GILD) Sued Over Outrageous Hepatitis C Drug Prices 12/15/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers 12/1/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
U.S. Court Overturns Bid By India's Ranbaxy Laboratories (RANBAXY.BO) To Block Launch Of Rival Generic Drugs 11/20/2014
Forward Pharma (FWP) Sues Biogen Idec (BIIB) Over Tecfidera Sales In Germany 11/18/2014
AbbVie (ABBV) Uses Patents To Ambush Gilead (GILD) 11/14/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
New AbbVie (ABBV) Head Blasts Canada’s Patent Laws On Drugs 10/24/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
Amgen (AMGN) Files Lawsuit Against Sanofi (SAN.PA) And Regeneron (REGN) For Patent Infringement 10/17/2014
Lawyers Have Documents That Prove Allergan Inc. (AGN) Misled Investors About Valeant (VRX): Ackman 10/17/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Chinese Court Hits GlaxoSmithKline (GSK) With $492M Bribery Fine 9/19/2014
FDA Panel Backs Limits On Testosterone Drugs 9/17/2014
AbbVie (ABBV), Teva Pharmaceutical Industries Limited (TEVA) Illegally Blocked Generic Version Of AndroGel: Federal Trade Commission 9/9/2014
Bristol-Myers Squibb Company (BMY) Takes Immunotherapy Rivalry With Merck & Co. (MRK) To The Courts 9/8/2014
Gilead Sciences, Inc. (GILD) Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries 9/5/2014
Pfizer Inc. (PFE) Is Liable For Harm Caused By A Generic Rival: Court 8/18/2014
Eisai Company, Ltd. (ESALY.PK) Sues The FDA To Regain "Lost" Marketing Time For Its Drugs 8/18/2014
AbbVie (ABBV) Decides Against Appealing A Ruling That Would Have Protected Gays 8/8/2014
As Pfizer Inc. (PFE) Settles Rapamune, Another Wave Of Lipitor Lawsuits Hit 8/8/2014
Pfizer Inc. (PFE) To Shell Out $35 Million To NC, Other States For Rapamune 8/7/2014
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen 7/28/2014
Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner 7/24/2014
Pfizer (PFE) Fights Off Shareholder Lawsuit 7/9/2014
Novartis AG (NVS) Issues New Research Guidelines After Japan Study Scandal 7/8/2014
GlaxoSmithKline (GSK) Risks Being Thrown Out Of China 7/7/2014
FDA Finally Proposes Social Media Guidelines For Drugmakers 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Pfizer Inc. (PFE) To Pay $325 Million In Neurontin Settlement 6/3/2014
GlaxoSmithKline (GSK) Dodged Millions In China Drug Tax Scam 5/20/2014
SEC Accuses Two Doctors Of Insider Trading After GTx, Inc. (GTXI) Clinical Trial Is Halted 5/20/2014
Jury Finds For Takeda Pharmaceutical Co. Ltd. (TKPYY) In Diabetes Drug Case 5/16/2014
Eli Lilly and Company (LLY) Loses Major Patent Case To Actavis (ACT) 5/16/2014
Mylan Inc. (MYL) Applauds Court's Ruling Dismissing Teva Pharmaceutical Industries Limited (TEVA)'s Suit Against FDA On Copaxone® 5/15/2014
Ex-Sanofi (France) (SAN.PA) Executive Gets 16 Months For Insider Trading 4/21/2014
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014
GlaxoSmithKline (GSK) Can't Catch A Break, Faces Bribery Allegations In Poland 4/14/2014
Roche (RHHBY), Novartis AG (NVS) Offices Raided Over Wet AMD Treatments 4/11/2014
Verdict In: Jury Orders Takeda Pharmaceutical Co. Ltd. (TKPYY), Eli Lilly and Company (LLY) To Pay $9 Billion In Damages Over Actos 4/8/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
Johnson & Johnson (JNJ) Gets $1.2 Billion Risperdal Judgment Tossed Out 3/21/2014
Business Bill Could Help Scientists Let Go By Pfizer Inc. (PFE) 3/19/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014
Maybe There Is Such A Thing As A Free Lunch - Vermont Considers Allowing Drug And Device Makers To Again Provide In-Office Meals To Healthcare Professionals 2/20/2014
Pfizer Inc. (PFE) Legal Exec Predicts Government Clampdown On CEO Quotes, Press Releases 2/14/2014
Boehringer Ingelheim Corporation Facing 2,000+ U.S. Lawsuits Over Blood Thinner 2/13/2014
Ex-SAC Trader Convicted Of Seeking Out Secrets Related To Experimental Alzheimer's Drug 2/7/2014
Abbott Laboratories (ABT) Labs Sued By Five Men Claiming Androgel Injuries 2/7/2014
Teva Pharmaceutical Industries Limited (TEVA) Asks Supreme Court To Review Copaxone Ruling 1/23/2014
Doc Admits He Leaked Secret ALZ's Trial Information To "Friend" At SAC 1/21/2014
Actavis (ACT) To Exit China As Unfriendly Government Not Worth It 1/17/2014
Gentium S.p.A. Shareholders Sue Over $1 Billion Jazz Pharmaceuticals plc (JAZZ) Deal 1/17/2014
Whistleblower Lawsuit Costs Genzyme Corporation (GENZ) $22 Million 1/6/2014
U.S. Supreme Court Refuses To Hear Ex-InterMune, Inc. (ITMN) CEO's Appeal 12/16/2013
GlaxoSmithKline (GSK) Paper At Center Of Fabricated Data Scandal Is Retracted 12/9/2013
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/9/2013
European Court May Force AbbVie (ABBV), InterMune, Inc. (ITMN) To Release Business Secrets 12/6/2013
Apotex Inc. Ordered To Pony Up $76 Million To AstraZeneca PLC (AZN) In Damages 12/4/2013
U.S. Supreme Court Rejects Teva Pharmaceutical Industries Limited (TEVA)'s Copaxone Petition 11/14/2013
Sanofi (SAN.PA) Files "First-Of-A-Kind" Lawsuit Against FDA Over OTC Drug 11/13/2013
FDA Slaps Aegerion Pharmaceuticals, Inc. (AEGR) CEO For "Serious" Violations Of Drug Promotion Law Following CNBC Interview 11/11/2013
Amarin Corporation PLC (AMRN) Appeals FDA Rescission of Special Protocol Agreement 11/8/2013
U.S. Appeals Court Revives Patent Fight Over AstraZeneca PLC (AZN) Drug 10/31/2013
Ex-Bristol-Myers Squibb Company (BMY) Executive Gets One Year in Prison for Insider Trading 10/24/2013
BioReference Laboratories, Inc. (BRLI) Sued by Myriad Genetics, Inc. (MYGN), Confident in Its Position 10/22/2013
Quest Diagnostics Inc. (DGX) Debuts Cheaper Genetic Test to Challenge Rival Myriad Genetics, Inc. (MYGN) 10/15/2013
Supreme Court Rejects Novartis AG (NVS) Bid to Hear Punitive Damages Case 10/8/2013
U.S. Court Lifts Ban on Competitor to AstraZeneca PLC (AZN)'s Nexium 10/2/2013
Sanofi (France) (SAN.PA) Settles Lawsuit Over Obesity Drug for $40 Million 9/20/2013
Eli Lilly and Company (LLY) Files $500 Million Lawsuit Against Canada 9/13/2013
Mold Prompts Recall of 5,000 Vials of Johnson & Johnson (JNJ)'s Schizophrenia Drug 9/13/2013
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013
Eli Lilly and Company (LLY) "Concerned" by China Bribery Allegations 9/10/2013
Federal Trade Commission Submits Proposed Amicus Brief Concerning "No-Authorized-Generic" Commitments in Drug Companies' Patent Settlements 8/20/2013
A Takeda Pharmaceutical Co. Ltd. (TKPYY) Manager Asks the Supreme Court to Review a Whistleblower Ruling 8/15/2013
OxyContin Maker, Purdue Pharma Won't Share List of Suspicious Doctors 8/13/2013
FDA Ordered to Cough Up Docs Regarding Gilead Sciences, Inc. (GILD) Drug 8/8/2013
India Revokes GlaxoSmithKline (GSK) Cancer Drug Patent in Latest Big Pharma Blow 8/2/2013
Biogen Idec, Inc. (Massachusetts) (BIIB): It's Unlikely Patient Death Was Caused by New MS Drug 7/24/2013
Novartis AG (NVS) Admits 2 Ex-Employees Plus Prominent Japanese Doc Involved in Data Scandal 7/23/2013
GlaxoSmithKline (GSK) Says Executives Appear to Have Broken Chinese Law 7/22/2013
Drugmaker Fees for FDA Review Would be Freed in U.S. House Bill 7/19/2013
SEC Comes Calling for AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) as FDA Panel Fallout Continues 7/12/2013
EU Fines H. Lundbeck A/S (LUN.CO) and Others $195 Million for Blocking Rival Drugs 6/19/2013
Novartis AG (NVS) Sacks 18 for Fabricating Sales Data 6/14/2013
The Supreme Court Rules Out Some - But Not All -- Gene Patents 6/13/2013
Another GlaxoSmithKline (GSK) Scandal in China: Bribing Docs to Prescribe Meds? 6/13/2013
Teva Pharmaceutical Industries Limited (TEVA), Sun Pharmaceutical Industries Ltd to Pay $2.15 Billion to Settle Pfizer Inc. (PFE) Patent Suit 6/12/2013
Sanofi (France) (SAN.PA) Fined $52 Million Over Plavix Smear Campaign in France 5/14/2013
Ranbaxy Laboratories (RANBAXY.BO) Pays $500 Million to Settle Long-Running Production Scandal 5/14/2013
Fired Exec Claims ReSearch Pharmaceutical Services (RPS), Inc. Violated Privacy Practices in Hiring 5/13/2013
Sanford Heisler Files $100 Million+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. (MRK) 5/9/2013
Former Johnson & Johnson (JNJ) Employee Sues Over Age Discrimination 5/9/2013
Bayer AG (BAYN.DE) Patent on Yaz Birth Control Pill Ruled Invalid 4/18/2013
Amgen (AMGN) to Pay $25 Million to Settle Kickback Allegations 4/17/2013
Eli Lilly and Company (LLY) Settles Wrongful Death Lawsuit 4/10/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
Syntrix Wins $96 Million Verdict Against Illumina, Inc. (ILMN) in DNA Patent Suit 3/15/2013
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples 3/13/2013
Merck & Co., Inc. (MRK) Hid Fosamax's Bone-Weakening Risks, Lawyer Contends 3/13/2013
Interpol, Dozens of Drug Makers Ramp Up Fight Against Counterfeit Drugs 3/12/2013
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013
Royalty Deal May Settle Lawsuit Over InterMune, Inc. (ITMN) Lung Drug 2/20/2013
Express Scripts Inc. Says Ernst & Young LLP Stole Secrets 2/20/2013
U.S. Appeals Court Finds AstraZeneca PLC (AZN)'s Seroquel XR Patent Infringed 2/15/2013
Merck & Co., Inc. (MRK) to Pay $688 Million to Settle Enhance Lawsuits 2/14/2013
Eli Lilly and Company (LLY) Threatens to Leave Canada Over Patent Rulings 2/14/2013
Otsuka Can Block Generic Abilify as Court Rejects Appeal 1/15/2013
Amgen (AMGN) Whistleblower Fights to Unseal Documents 1/15/2013
Pfizer Inc. (PFE) Can be Sued for Injury Caused by Generic 1/14/2013
Teva Pharmaceutical Industries Limited (TEVA) Asks FDA Not to Approve Biogen Idec, Inc. (Massachusetts) (BIIB) MS Drugs 1/14/2013
Eli Lilly and Company (LLY) May Have a $15 Billion "Wild Card" Up Its Sleeve: Analysis 1/7/2013
Servier Founder Faces Manslaughter Charges 12/14/2012
Pfizer Inc. (PFE) to Pay $55 Million to Settle Protonix Case 12/13/2012
Boehringer Ingelheim Corporation Sued by Hundreds Over Bleeding Tied to Pradaxa 12/11/2012
KV Pharmaceutical to Pay Hologic, Inc. (HOLX) $60 Million to Settle Makena Drug Dispute 12/11/2012
The Op-Ed: Johnson & Johnson (JNJ) Patent Move is "Inadequate" 11/30/2012
GlaxoSmithKline (GSK) Pays $90 Million to Settle States' Avandia Claims 11/16/2012
GlaxoSmithKline (GSK) Employee Blows Whistle on Drug Promotions 11/13/2012
Tiny Tekmira Pharmaceuticals Corporation Lands $65 Million Settlement Plus $10 Million in Near-Term Milestone Payments From Alnylam Pharmaceuticals (ALNY) 11/13/2012
Girl Dies as Pluristem Therapeutics (PSTI) Sells on Gains With Miracle Cells 11/9/2012
Johnson & Johnson (JNJ) Settles 845 Levaquin Lawsuits 11/2/2012
FDA Warns Celltex Therapeutics Corporation Over Violations 10/17/2012
Pfizer Inc. (PFE) to Shell Out $164 Million in Investor Lawsuit Over Celebrex 10/10/2012
Johnson & Johnson (JNJ) Loses a Preemption Case Over Infant Tylenol 10/10/2012
SEC Investigates Pfizer Inc. (PFE) Over Odd Results 10/9/2012
FDA: New England Compound Center Drugs Tied to Meningitis 10/8/2012
Johnson & Johnson (JNJ) CEO Dodges Bullet in Risperdal Drug Case 9/21/2012
Johnson & Johnson (JNJ) Settles Risperdal Side Effect Lawsuit 9/11/2012
Use of Gilead Sciences, Inc. (GILD) Stribild HIV Pill May be Limited in U.S. 9/10/2012
India Court Rules for Cipla Ltd. Against Roche (RHHBY) in Patent Case 9/10/2012
VIVUS, Inc. (VVUS) Tumbles on Concerns About Generic Qsymia 8/21/2012
Myriad Genetics, Inc. (MYGN) Wins Gene Patent Ruling From US Appeals Court 8/17/2012
Gilead Sciences, Inc. (GILD) Warned by Democrats Over "Quad" Pricing 8/16/2012
Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes 8/8/2012
U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox 8/6/2012
VIVUS, Inc. (VVUS) Diet Pill Patents are Questioned and Stock Sinks 7/23/2012
U.S. Charges 48 People in $500 Million Medicaid Drug Scheme 7/18/2012
Merck & Co., Inc. (MRK)'s Schering-Plough Corporation (SGP)'s K-Dur Pay-for-Delay Ruling Reversed 7/17/2012
K-V Pharmaceutical Company (KV-A) Sues FDA Over Makena in Fight for Survival 7/6/2012
Roche (RHHBY) Ignores 80,000 Cases of Possible Adverse Drug Reactions 7/3/2012
GlaxoSmithKline (GSK) Settles Healthcare Fraud Case for $3 Billion 7/2/2012
Abbott Laboratories (ABT) is Challenging Biotech Drug Copies, Protects Humira's Secrets 6/25/2012
Johnson & Johnson (JNJ) Close to Settling Off-Label Probes 6/21/2012
Pfizer Inc. (PFE) Paid $896 Million in Prempro Accords, Filing Shows 6/19/2012
KV Pharmaceutical : FDA Issues New Update on Makena 6/18/2012
FDA OKs Multiple Companies to Sell Generic Plavix as Drug Falls Off Patent Cliff 5/18/2012
Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Gets FDA Fast Track 5/15/2012
FDA Voices Caution About Popular Bone Drugs, Including Novartis AG (NVS)'s Reclast 5/11/2012
Onetime "King of Biotech" Runs Afoul of Law Again 5/11/2012
Feds Arrest Thieves Who Fleeced Eli Lilly and Company (LLY) Warehouse in $70 Million Heist 5/4/2012
Consumer Group to FDA: Pull Novo Nordisk A/S (NVO)'s Victoza Off the Market 4/23/2012
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents 4/11/2012
Icahn Sues Amylin Pharmaceuticals, Inc. (AMLN) in Shake-up Try 4/10/2012
Pfizer Inc. (PFE) Execs to Stand Trial for Cover-up of Drug Trial Results 4/4/2012
FDA Finds More Fake Batches of Roche (RHHBY)'s Avastin Cancer Drug in U.S. 4/4/2012
Supreme Court Orders New Look at Gene Patents 3/26/2012
Apotex Inc. Drug Maker Sues U.S. for $520 Million Under NAFTA 3/15/2012
Forest Laboratories, Inc. (FRX), Johnson & Johnson (JNJ) Sue Several Drug Makers Over Bystolic 3/15/2012
Government Nixes Tentative $1 Billion Settlement With Johnson & Johnson (JNJ) 3/12/2012
Former FDA Chemist Gets 5 Years for Insider Trading 3/7/2012
Supreme Court Rejects Johnson & Johnson (JNJ)'s Lawsuit Over Abbott Laboratories (ABT)'s Humira 2/22/2012
Pfizer Inc. (PFE)'s Wyeth (WYE) Unit Seeks $960 Million in Damages From Sun Pharmaceutical Industries Ltd 2/20/2012
Illumina, Inc. (ILMN) Announces Favorable Patent Claim Construction Ruling in Litigation Against Complete Genomics, Inc. 2/16/2012
Roche (RHHBY) Warns of Counterfeit Avastin in the U.S. 2/16/2012
GlaxoSmithKline (GSK) Settles 20,000 Lawsuits Over Avandia, Lawyer Says 2/2/2012
Johnson & Johnson (JNJ) to Pay $158 Million to Settle Texas Risperdal Case 1/20/2012
Roche (RHHBY) Refuses to Disclose Tamiflu Data: Scientists 1/18/2012
House Democrats Probe ADHD Drug Shortage 1/18/2012
Johnson & Johnson (JNJ) to Pay $1 Billion to Settle Risperdal Marketing Probe 1/6/2012
Illumina, Inc. (ILMN) Accuses Life Technologies (LIFE) of Infringing Patent 12/29/2011
Alexza Pharmaceuticals, Inc. (ALXA) Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review 12/9/2011
FDA Cites Violations at Three Novartis AG (NVS) Plants 12/7/2011